Within the landscape of weight loss solutions, the Tracey Bell Clinic introduces two pivotal medications, Mounjaro and Wegovy, noted for their substantial efficacy in augmenting weight loss alongside dietary and exercise modifications
| 03.12.26 | 6 min read
Financial barriers to access Though the 40-50 age group has the highest observed rates of GLP-1 use, the savings compound if people start in their twenties and thirties
However, recent regulatory crackdowns on compounded GLP1 medications have reduced access to cheaper alternatives, leading to a drop in usage among cost-sensitive populations
These compounds, also called glucocorticosteroids, such as prednisone, dexamethasone, and triamcinolone, are prohibited in competition due to their metabolic and anti-inflammatory effects